DNA methyltransferase inhibitor

5-Aza-2’-deoxycytidine (5-AzadCyD, 5-Aza-CdR, decitabine) is a specific inhibitor of DNA methylation. It functions in a similar manner to aza-citidine, although decitabine can only be incorporated into DNA strands while azacitidine can be incorporated into both DNA and RNA chains.
5-AzadCyD is a prodrug that requires activation via phosphorylation by deoxycytidine kinase. The nucleotide analog is incorporated into DNA, where it produces an irreversible inactivation of DNA methyltransferase. 5-AzadCyD was demonstrated to be a potent antineoplastic agent against leukemia and tumors in animal models [1,2].


Working concentration: 0.1-10 μM
CAS number:
Formula: C8H12N4O4
Molecular weight: 228.2
Solubility: Soluble in acetic acid:water (1:1 v/v) at 50 mg/ml


   • 10 mg


1. Christman JK., 2002. 5-Azacytidine and 5-aza-20-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483–5495.
2. Kulis M. & Esteller M., 2010. DNA methylation and cancer. Adv Genet. 2010;70:27-56


5-Aza-2'-deoxycytidine DISCONTINUED

Description DNA methyltransferase inhibitor
Cat. Codemet-adc-1
Unit Size10 mg
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".